Palliative resection for advanced gastric and junctional adenocarcinoma: Which patients will benefit from surgery?

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1240-1249

  Mariette, Christophe ^a,b   Bruyère, Emilie ^a   Messager, Mathieu ^a   Pichot Delahaye, Virginie ^c   Paye, François ^d   Dumont, Frédéric ^e   Brachet, Dorothée ^f   Piessen, Guillaume ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; FLUOROURACIL; IRINOTECAN;

ADULT; ADVANCED CANCER; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOSIS; CONFERENCE PAPER; FEMALE; FRANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH SURGERY;

ADENOCARCINOMA; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84875161931     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2687-6     Document Type: Conference Paper

References (31)

1. A Jemal R Siegel E Ward, et al. 2006 Cancer statistics, 2006 CA Cancer J Clin. 56 106 130 16514137 10.3322/canjclin.56.2.106
2. DM Parkin P Pisani J Ferlay 1999 Global cancer statistics CA Cancer J Clin. 49 33-64 1
3. V Catalano R Labianca GD Beretta G Gatta F de Braud E Van Cutsem 2009 Gastric cancer Crit Rev Oncol Hematol. 71 127 164 19230702 10.1016/j.critrevonc. 2009.01.004
4. Wagner AD, Unverzagt S, Grothe W, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010;3:CD004064.
5. K Ouchi T Sugawara H Ono, et al. 1998 Therapeutic significance of palliative operations for gastric cancer for survival and quality of life J Surg Oncol. 69 41 44 9762890 10.1002/(SICI)1096-9098(199809)69:1<41::AID- JSO8>3.0.CO;2-K 1:STN:280:DyaK1cvjtlymtg%3D%3D
6. H Isozaki K Okajima Y Kawashima, et al. 1993 Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery J Surg Oncol. 53 247 251 8341056 10.1002/jso.2930530412 1:STN:280:DyaK3szktFWmtg%3D%3D
7. S Maekawa M Saku Y Maehara, et al. 1996 Surgical treatment for advanced gastric cancer Hepatogastroenterology. 43 178 186 8682459 1:STN:280: DyaK283mvVOrsQ%3D%3D
8. GB Thompson JA van Heerden MG Sarr 1993 Adenocarcinoma of the stomach: are we making progress? Lancet. 342 713 718 8103825 10.1016/0140-6736(93)91711-T 1:STN:280:DyaK3szot1Wkug%3D%3D
9. HH Hartgrink H Putter E Klein Kranenbarg JJ Bonenkamp CJ van de Velde 2002 Value of palliative resection in gastric cancer Br J Surg. 89 1438 1443 12390389 10.1046/j.1365-2168.2002.02220.x 1:STN:280:DC%2BD38njt1anug%3D%3D
10. SC Cunningham RD Schulick 2007 Palliative management of gastric cancer Surg Oncol. 16 267 275 17881220 10.1016/j.suronc.2007.08.004
11. M Messager JH Lefevre V Pichot-Delahaye A Souadka G Piessen C Mariette 2011 The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study Ann Surg. 254 684 693 22005144 10.1097/SLA.0b013e3182352647
12. C Mariette G Piessen N Briez C Gronnier JP Triboulet 2011 Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 12 296 305 21109491 10.1016/S1470-2045(10)70125-X
13. O Nazli I Yaman T Tansuǧ AS Işgüder AD Bozdag H Bölükbaşi 2007 Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma Hepatogastroenterology. 54 298 303 17419279
14. S Gretschel R Siegel L Estévez-Schwarz M Hünerbein U Schneider PM Schlag 2006 Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis Br J Surg. 93 1530 1535 17051604 10.1002/bjs.5513 1:STN:280:DC%2BD28noslOrug%3D%3D
15. D Cunningham WH Allum SP Stenning, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med. 355 11 20 16822992 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D
16. M Ychou V Boige JP Pignon, et al. 2011 Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol. 29 1715 1721 21444866 10.1200/JCO.2010.33.0597 1:CAS:528:DC%2BC3MXnslCjt7w%3D
17. Sobin LH, Wittekind C. UICC TNM Classification of malignant tumors. 6th edn. New York: Wiley-Liss, 2002.
18. G Piessen M Messager E Leteurtre JP Triboulet C Mariette 2009 Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation Ann Surg. 250 878 887 19855261 10.1097/SLA.0b013e3181b21c7b
19. K Welvaart PL de Jong 1986 Palliation of patients with carcinoma of the lower esophagus and cardia: the question of quality of life J Surg Oncol. 32 197 199 2426520 10.1002/jso.2930320402 1:STN:280:DyaL283otlaitA%3D%3D
20. JR Monson JH Donohue DC McIlrath MB Farnell DM Ilstrup 1991 Total gastrectomy for advanced cancer. A worthwhile palliative procedure Cancer 68 1863 1868 1717128 10.1002/1097-0142(19911101)68:9<1863::AID- CNCR2820680902>3.0.CO;2-1 1:STN:280:DyaK38%2FgsFartQ%3D%3D
21. AW Boddie Jr MJ McMurtrey GG Giacco CM McBride 1983 Palliative total gastrectomy and esophagogastrectomy. A reevaluation Cancer 51 1195 1200 6186352 10.1002/1097-0142(19830401)51:7<1195::AID-CNCR2820510705>3.0.CO;2-V
22. GA Ekbom JJ Gleysteen 1980 Gastric malignancy: resection for palliation Surgery. 88 476 481 6158763 1:STN:280:DyaL3M%2FjsVSltg%3D%3D
23. TJ Miner DP Jaques MS Karpeh MF Brennan 2004 Defining palliative surgery in patients receiving noncurative resections for gastric cancer J Am Coll Surg. 198 1013 1021 15194084 10.1016/j.jamcollsurg.2004.02.007
24. C Brigand C Arvieux FN Gilly O Glehen 2004 Treatment of peritoneal carcinomatosis in gastric cancers Dig Dis. 22 366 373 15812161 10.1159/000083600 1:STN:280:DC%2BD2M7nvVymsg%3D%3D
25. KH Huang CW Wu WL Fang, et al. 2010 Palliative resection in noncurative gastric cancer patients World J Surg. 34 1015 1021 20145923 10.1007/s00268-010- 0467-7
26. S Mizutani T Shioya K Maejima, et al. 2007 Significance of gastrectomy as palliative surgery for gastric carcinoma with pyloric stenosis J Nihon Med Sch. 74 241 245 10.1272/jnms.74.241
27. S Scabini E Rimini E Romairone R Scordamaglia D Pertile V Ferrando 2009 Factors predicting survival in surgical palliative resection of stage IV colorectal cancer Minerva Chir. 64 303 306 19536056 1:STN:280: DC%2BD1MvislOksQ%3D%3D
28. O Glehen V Schreiber E Cotte, et al. 2004 Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer Arch Surg. 139 20 26 14718269 10.1001/archsurg.139.1.20 1:STN:280:DC%2BD2c%2FitVKqtg%3D%3D
29. K Fujitani M Yamada M Hirao Y Kurokawa T Tsujinaka 2011 Optimal indications of surgical palliation for incurable advanced gastric cancer presenting with malignant gastrointestinal obstruction Gastric Cancer. 14 353 359 21559861 10.1007/s10120-011-0053-1
30. JZ Zhang HS Lu CM Huang, et al. 2011 Outcome of palliative total gastrectomy for stage IV proximal gastric cancer Am J Surg. 202 91 96 21600557 10.1016/j.amjsurg.2010.05.014
31. YJ Bang E Van Cutsem A Feyereislova, et al. 2010 Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet. 376 687 697 20728210 10.1016/S0140-6736(10)61121-X 1:CAS:528:DC%2BC3cXhtVymt7zO